Status
Conditions
Treatments
About
The primary hypothesis of the present study is that supplementation with the Tension Relief test product will reduce the severity of symptoms of a tension headache.
Full description
Patients will begin taking the capsules at the onset of headache symptoms. Onset is defined as the point in time the participant feels that it is necessary to take the test product for relief of symptoms. When the participant decides to take the test product, they will report symptoms in the headache diary prior to taking the product and rate their symptoms on a 10-point Mankoski scale. After consuming the product, the participant will complete a Mankoski scale at 15 minutes, 30 minutes and 1 hour after taking the product. If needed the participant will be allowed to take alternative medication (alternative treatment) after an hour after taking the product. If alternative medication is taken, the participant will record this in their headache diary.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Adult candidates who are in overall good health and who suffer from mild to moderate tension headaches.
Participants will be deemed to be in good health if they do not report any of the existing medical conditions asked about in the screening questionnaire.
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
117 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal